Experts Warn About Beovu Vision Loss Side Effects

Via America’s Lawyer: Attorney Brandon Bogle joins Mike Papantonio to explain how a popular injection treatment for macular degeneration called Beovu is actually causing permanent vision loss and blindness in many of its recipients. In yet another example of the FDA's oversight, Novartis's drug has put thousands of elderly patients at risk.

Become a member today!

Support us by becoming a monthly patron on Patreon, and help keep progressive media alive!

Find our merchandise at Teespring

Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content!

Support Ring of Fire by subscribing to our YouTube channel

Be sociable! Follow us on:

Follow more of our stories at

Subscribe to our podcast

*This transcript was generated by a third-party transcription software company, so please excuse any typos.

Earlier this year, vision experts began warning doctors about the dangers of Beovu. It's a drug intended to treat vision loss that's actually causing some patients to go completely blind. I have attorney Brandon Bogle with me now, an attorney who's had extraordinary experience with very complex cases like this. I'm glad you're working this case. Give us a rundown, give us a 10,000 foot before we talk about details here.

Yeah, so this is a drug that's manufactured by Novartis. It's actually a pretty new drug on the market. It's been out for less than two years, but pretty quickly after it was made available in the United States, there were a significant number of patients who were taking the drug by injection and pretty immediately suffering partial or complete vision loss that now experts in the field have very strongly tied to the use of this drug.

Okay. So a patient goes, and first of all, there are many alternatives aren't there. They don't even have to use this drug. This drug does not even have to be on the market, right?

That's absolutely correct.

It's a moneymaker. So Novartis is saying, let's jump into that. Other people are making money on it. Me too. I want to make, I want to make some money on this too. How extensive is this condition in a person uses Beovu, which is an injection, isn't it?

It is, it's an injection you get in your, in your doctor's office. Usually an ophthalmologist will give it to you in their office.

Do they inject it directly into the eye?

They do, yes.

Okay. And so how often does that take place?

It's, it's something that you have to get periodically over a period of months, but usually you come in every month or so and get an injection.

Okay. And so from a physiological standpoint, what we're seeing is we're seeing what we call miniature eye strokes, right?

Correct.

You're having blood vessels that are exploding in the back, Beovu's creating some unusual protein as I understand it.

Right.

The protein is, is affecting the ocular system in the back of the eye, right?

That's right. Yeah. You get a blood clot in the back of your eye and you pretty immediately cannot see, which has gotta be a very startling thing to go through.

Is it reversible once we get away from Beovu, is it reversible once you do that macular damage?

Unfortunately, generally, no, it is not. The patients are stuck with the loss of vision that they experienced following the clot in the eye itself.

What type of patient is more at risk here? I mean, who goes to use Beovu to begin with?

Yeah. So it's treats age-related macular degeneration, which typically occurs in patients 50 years old or older. So that's the population that's going to be taking the drug and that condition itself causes a very slow deterioration of eyesight. But what unfortunately we see with this drug is it causes a rapid onset of oftentimes complete blindness.

Mm. Okay. Now let me get this right. Because we hear the same thing every time. FDA did nothing.

Correct.

We think FDA does testing, they don't. If Novartis, if, if, if Novartis phonied up the clinical data, we won't know until you take those depositions. Did they have, did they have clinical data that should have shown them that this has the ability to cause absolute total blindness? That's what you're going to find out.

Right. And, and what we already are seeing, and just very early on in this process is they did do exactly that.

#rof #trofire #theringoffire #progressivenews